In The News,
Most Favored Nation (MFN) Model
Conducted rapid analysis of Medicare rulemaking on the Most Favored Nation model introduced by CMMI. Assessed methodology, drugs impacted, and provider perspective. Modeled drug-specific impact per administration and annually over the model’s 4 year transition period using ADVI Strategic Analytics and Value Economics (SAVE), and modeled the specialty-level impact for providers based on historical billing. Developed and led market access and field reimbursement training, including key messages and FAQs for field teams.